PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice

Willeke de Haan, Jitske de Vries-van der Weij, Isabel M. Mol, Menno Hoekstra, Johannes A. Romijn, J. Wouter Jukema, Louis M. Havekes, Hans M. G. Princen, Patrick C. N. Rensen

Research output: Contribution to JournalArticleAcademicpeer-review

31 Citations (Scopus)


Pregnane X receptor (PXR) agonism has been shown to affect multiple steps in both the synthesis and catabolism of HDL, but its integrated effect on HDL metabolism in vivo remains unclear. The aim of this study was to evaluate the net effect of PXR agonism on HDL metabolism in ApoE3-Leiden (E3L) and E3L.CETP mice, well-established models for human-like lipoprotein metabolism. Female mice were fed a diet with increasing amounts of the potent PXR agonist 5-pregnen-3beta-ol-20-one-16alpha-carbonitrile (PCN). In E3L and E3L.CETP mice, PCN increased liver lipids as well as plasma cholesterol and triglycerides. However, whereas PCN increased cholesterol contained in large HDL-1 particles in E3L mice, it dose-dependently decreased HDL-cholesterol in E3L.CETP mice, indicating that CETP expression dominates the effect of PCN on HDL metabolism. Analysis of the hepatic expression of genes involved in HDL metabolism showed that PCN decreased expression of genes involved in HDL synthesis (Abca1, Apoa1), maturation (Lcat, Pltp) and clearance (Sr-b1). The HDL-increasing effect of PCN, observed in E3L mice, is likely caused by a marked decrease in hepatic SR-BI protein expression, and completely reversed by CETP expression. We conclude that chronic PXR agonism dose-dependently reduces plasma HDL-cholesterol in the presence of CETP
Original languageEnglish
Pages (from-to)191-197
JournalBiochimica et Biophysica Acta-Molecular and Cell Biology of Lipids
Issue number3
Publication statusPublished - 2009

Cite this